Theranostic Nanomedicine for Malignant Gliomas

Theranostic Nanomedicine for Malignant Gliomas

Brain tumors mainly originate from glial cells and are classified as gliomas. Malignant gliomas represent an incurable disease; indeed, after surgery and chemotherapy, recurrence appears within a few months, and mortality has remained high in the last decades. This is mainly due to the heterogeneity...

Full description

Bibliographic Details
Main Authors: Michele d'Angelo, Vanessa Castelli, Elisabetta Benedetti, Andrea Antonosante, Mariano Catanesi, Reyes Dominguez-Benot, Giuseppina Pitari, Rodolfo Ippoliti, Annamaria Cimini
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
theranostic nanoplatform
brain tumors
targeted therapy
drug delivery
diagnosis
Online Access:https://www.frontiersin.org/article/10.3389/fbioe.2019.00325/full

Internet

https://www.frontiersin.org/article/10.3389/fbioe.2019.00325/full

Similar Items